Evidence map›Paper›PMID 24485804›Full record

ArticleImmunity2014

The transcription factor IRF8 activates integrin-mediated TGF-β signaling and promotes neuroinflammation.

Yuko Yoshida, Ryusuke Yoshimi, Hiroaki Yoshii, Daniel Kim, Anup Dey, Huabao Xiong, Jeeva Munasinghe, Itaru Yazawa, Michael J O'Donovan, Olga A Maximova and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 148 citations in OpenAlex.

  1. Priming of CD8Nature neuroscience · 2026
    Article
  2. CD8bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Context-dependent TGFβ family signalling in cell fate regulation.Nature reviews. Molecular cell biology · 2023
    Review
  17. Mechanism of transforming growth factor-Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2023
    Article
  18. Novel CH25HJournal of neuroinflammation · 2023
    Article
  19. Epigenetics of Inflammatory Bowel Diseases.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2023
    Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Yuko YoshidaProgram in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, MD 20892, USA.
Ryusuke YoshimiProgram in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, MD 20892, USA.
Hiroaki YoshiiProgram in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, MD 20892, USA.
Daniel KimProgram in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, MD 20892, USA.
Anup DeyProgram in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, MD 20892, USA.
Huabao XiongImmunology Institute, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA.
Jeeva MunasingheLaboratory of Functional and Molecular Imaging, NINDS, National Institutes of Health, Bethesda, MD 20892, USA.
Itaru YazawaLaboratory of Neural Control, NINDS, National Institutes of Health, Bethesda, MD 20892, USA.
Michael J O'DonovanLaboratory of Neural Control, NINDS, National Institutes of Health, Bethesda, MD 20892, USA.
Olga A MaximovaLaboratory of Infectious Diseases, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.
Suveena SharmaLaboratory of Immunology, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.
Jinfang ZhuLaboratory of Immunology, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.
Hongsheng WangLaboratory of Immunogenetics, NIAID, National Institutes of Health, Rockville, MD 20892, USA.
Herbert C MorseLaboratory of Immunogenetics, NIAID, National Institutes of Health, Rockville, MD 20892, USA.
Keiko OzatoProgram in Genomics of Differentiation, NICHD, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: ozatok@nih.gov.
National Institutes of Health · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USNational Institute of Neurological Disorders and Stroke · USIcahn School of Medicine at Mount Sinai · USNational Institute of Allergy and Infectious Diseases · US

Funding

Transcriptional Regulation of Immune Cell Development, Activation and FunctionsZIAAI001169 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI ZHU, JINFANG · 2012 to 2025
$21.8M
Mechanisms of Rhythmicity in the Spinal cordZIANS003022 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI O'DONOVAN, MICHAEL · 2009 to 2021
$18.7M
Gene Regulation In The Immune SystemZIAHD001310 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI OZATO, KEIKO · 2009 to 2025
$15.0M
Molecular Regulation of B-Cell Differentiation and FunctionZIAAI001024 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MORSE, HERBERT · 2009 to 2018
$8.3M
Molecular Mechanisms in Innate immunityZIAAI001057 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MORSE, HERBERT · 2009 to 2018
$4.7M
Intramural NIH HHS ZIA AI001024Intramural NIH HHS ZIA AI001169
6 · The paper itself

Abstract

Recent epidemiological studies have identified interferon regulatory factor 8 (IRF8) as a susceptibility factor for multiple sclerosis (MS). However, how IRF8 influences the neuroinflammatory disease has remained unknown. By studying the role of IRF8 in experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, we found that Irf8(-/-) mice are resistant to EAE. Furthermore, expression of IRF8 in antigen-presenting cells (APCs, such as macrophages, dendritic cells, and microglia), but not in T cells, facilitated disease onset and progression through multiple pathways. IRF8 enhanced αvβ8 integrin expression in APCs and activated TGF-β signaling leading to T helper 17 (Th17) cell differentiation. IRF8 induced a cytokine milieu that favored growth and maintenance of Th1 and Th17 cells, by stimulating interleukin-12 (IL-12) and IL-23 production, but inhibiting IL-27 during EAE. Finally, IRF8 activated microglia and exacerbated neuroinflammation. Together, this work provides mechanistic bases by which IRF8 contributes to the pathogenesis of MS.

Indexed as

Signal TransductionAnimalsCells, CulturedDendritic CellsEncephalomyelitis, Autoimmune, ExperimentalFlow CytometryInflammationIntegrinsInterferon Regulatory Factor-8Interferon Regulatory FactorsMacrophagesMiceMice, KnockoutRNA, MessengerTransforming Growth Factor betaIntegrinsInterferon Regulatory Factor-8Interferon Regulatory FactorsRNA, MessengerTransforming Growth Factor beta

Identifiers

PMID24485804
PMCPMC4105266
OpenAlexW2169749019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.